Ascend Education Guides Over 500 Hong Kong Migrant Families in Navigating the UK Education System Rimini Street Presenting at Gartner® IT Symposium/Xpo™ Events Across the Globe
Executives will discuss strategies for driving innovation in IT and ERP at events in Orlando,…
monday.com Named a 2023 Gartner® Magic Quadrant™ Leader for Adaptive Project Management and Reporting
monday.com evaluated on ‘ability to execute’ and ‘completeness of vision’ NEW YORK & TEL AVIV,…
Skeletons Welcome for Halloween! Not So Welcome in Data, But Enterprise Search Can Help
Most people enjoy a good scare for Halloween. Much less delightful are skeletons like intellectual…
The Technology Sector Is The Most Valuable Sector In 2023
That’s according to the experts at City Index, who revealed the biggest companies in 1980, 2000…
Avidex Promotes Lance Bowers as New COO
CARY, N.C. — Sept. 20, 2023 — Avidex, a leading provider of audiovisual and collaboration…
Skyhawk Security Launches Comprehensive Generative AI Benchmark Ranking LLMs Based on Cyber Threat Scoring Capabilities
Free resource analyzes the performance of ChatGPT, Google BARD, Claude, LLAMA2-based open LLMs TEL AVIV,…
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
WARREN, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company…
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
Company to Lead Symposiums at ICCS and ESCCA FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE)…
Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100
Company’s Chief Medical Officer and FDA veteran receives distinguished award for notable contributions to clinical…
Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
BOSTON and ATLANTA, Sept. 20, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase…
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery (NASDAQ:…
Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023
MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
Inozyme Pharma to Host Virtual Investor and Analyst Event on Sep. 26, 2023
Company to share interim data updates from ongoing Phase 1/2 trials of INZ-701 in adults…
LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE’s First-in-Class PP2A Inhibitor, LB-100, Plus GSK’s Immunotherapy, Dostarlimab, in Clear-Cell Ovarian Cancer
The Phase 1b Clinical Trial Focuses on Assessing the Safety and Efficacy of the Two-Drug…
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
Partnership based on a highly protective vaccine candidate identified by Evaxion’s EDEN™ platform The collaboration…
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
MALVERN, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclinical Studies
H3N2 HAI Response Vaccination with PDS0202 Provides broadly effective HAI antibody responses (minimum 1:40 ratio)…
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
– Based on a novel human cytomegalovirus vector platform, VIR-1388 was designed with the goal…
Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
SUNNYVALE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Corsair Pharma, Inc., a private biopharmaceutical company…
NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
NAARDEN, The Netherlands and MIAMI, Sept. 20, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….